Oncotarget

Vol 10, No 9

January 29, 2019

View Archive »

Order a Reprint

About The Cover

The cover for issue 9 of Oncotarget features Figure 3, "Kaplan–Meier curves showing the survival outcomes of mucosal melanoma patients," by Quek, et al.

Table of Contents

Editorial

Flipping the “switch” on mutant p53 by zinc metallochaperones: how a brief pulse of zinc can reactivate mutant p53 to kill cancer

Flipping the “switch” on mutant p53 by zinc metallochaperones: how a brief pulse of zinc can reactivate mutant p53 to kill cancer

https://doi.org/10.18632/oncotarget.26561

Xin Yu,  and Darren R. Carpizo
918-919
PDF  |  Order a Reprint

Modes of immunosuppression in glioblastoma microenvironment

Modes of immunosuppression in glioblastoma microenvironment

https://doi.org/10.18632/oncotarget.26643

Suvi Lehtipuro, Matti Nykter,  and Kirsi J. Granberg
920-921
PDF  |  Order a Reprint

Tumor stroma as contributing factor in the lymph node metastases process?

Tumor stroma as contributing factor in the lymph node metastases process?

https://doi.org/10.18632/oncotarget.26644

Wilma E. Mesker, Gabi W. van Pelt,  and Rob A.E.M. Tollenaar
922-923
PDF  |  Order a Reprint

A hint from zebrafish models of hepatic tumorigenesis: Targeting stearoyl-CoA desaturase

A hint from zebrafish models of hepatic tumorigenesis: Targeting stearoyl-CoA desaturase

https://doi.org/10.18632/oncotarget.26645

Kunpeng Lv, Fei Fei,  and Xu Wang
924-925
PDF  |  Order a Reprint

Research Perspectives

Oncofertility counselling in premenopausal women with HER2-positive breast cancer

Oncofertility counselling in premenopausal women with HER2-positive breast cancer

https://doi.org/10.18632/oncotarget.26565

Matteo Lambertini, Isabelle Demeestere, Giulia Viglietti,  and Evandro de Azambuja
926-929
Abstract  |  PDF  |  HTML  |  Order a Reprint

Research Papers

Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas

Recurrent hotspot SF3B1 mutations at codon 625 in vulvovaginal mucosal melanoma identified in a study of 27 Australian mucosal melanomas

https://doi.org/10.18632/oncotarget.26584

Camelia Quek, Robert V. Rawson, Peter M. Ferguson, Ping Shang, Ines Silva, Robyn P.M. Saw, Kerwin Shannon, John F. Thompson, Nicholas K. Hayward, Georgina V. Long, Graham J. Mann, Richard A. Scolyer,  and James S. Wilmott
930-941
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncology

Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncology

https://doi.org/10.18632/oncotarget.26604

Gerald W. Prager, Matthias Unseld, Fredrik Waneck, Robert Mader, Fritz Wrba, Markus Raderer, Thorsten Fuereder, Phillip Staber, Ulrich Jäger, Markus Kieler, Daniela Bianconi, Mir Alireza Hoda, Lukas Baumann, Alexander Reinthaller, Walter Berger, Christoph Grimm, Heinz Kölbl, Maria Sibilia, Leonhard Muellauer,  and Christoph Zielinski
942-952
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

TNFR1 single nucleotide polymorphisms are not associated with cervical HPV-induced pre-malignant lesion but regulate in situ cervical TNFR1 expression

TNFR1 single nucleotide polymorphisms are not associated with cervical HPV-induced pre-malignant lesion but regulate in situ cervical TNFR1 expression

https://doi.org/10.18632/oncotarget.26627

Natália Pereira da Rocha, Elyzabeth Avvad-Portari, Fábio Russomano, Eric Henrique Roma, Amanda Chaves Pinto, Evandro Klumb, Jacyara Macedo, Ana Teresa Gomes Fernandes,  and Maria da Glória Bonecini-Almeida
953-965
Abstract  |  PDF  |  HTML  |  Order a Reprint

Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer

Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer

https://doi.org/10.18632/oncotarget.26629

Chara Papadaki, Giannis Stoupis, Leuteris Tsalikis, Alexia Monastirioti, Maria Papadaki, Neofytos Maliotis, Michalis Stratigos, Georgios Mastrostamatis, Dimitrios Mavroudis,  and Sofia Agelaki
966-981
Abstract  |  PDF  |  HTML  |  Order a Reprint

Immune response characterization of endometrial cancer

Immune response characterization of endometrial cancer

https://doi.org/10.18632/oncotarget.26630

Yuexin Liu
982-992
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Reviews

CD248: A therapeutic target in cancer and fibrotic diseases

CD248: A therapeutic target in cancer and fibrotic diseases

https://doi.org/10.18632/oncotarget.26590

Beverly A. Teicher
993-1009
Abstract  |  PDF  |  HTML  |  Order a Reprint

Corrections

Correction: CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway

Correction: CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway

https://doi.org/10.18632/oncotarget.26656

Teng Hou, Lijie Zhou, Longwang Wang, Gallina Kazobinka, Xiaoping Zhang,  and Zhaohui Chen
1010-1010
Correction  |  PDF

Errata

Erratum: Ocular toxicities associated with targeted anticancer agents: an analysis of clinical data with management suggestions

Erratum: Ocular toxicities associated with targeted anticancer agents: an analysis of clinical data with management suggestions

https://doi.org/10.18632/oncotarget.26658

Chen Fu, Dan S. Gombos, Jared Lee, Goldy C. George, Kenneth Hess, Andrew Whyte,  and David S. Hong
1011-1013
Erratum  |  PDF


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC